Skip to main content

Inspire Medical Systems, Inc.

corporate_fare Company Profile

Inspire Medical Systems, Inc.

INSP·NYSE·Industrial Applications And Services·CIK 0001609550

Inspire Medical Systems, Inc. is a medical technology company that develops and sells minimally invasive solutions for patients with obstructive sleep apnea ("OSA"). The company's main product is the Inspire system, a neurostimulation technology approved by the FDA, the European Union ("EU") Medical Devices Regulation, and Japan's Pharmaceuticals and Medical Devices Agency. This system is designed to treat patients with moderate to severe OSA. The Inspire system is a closed-loop solution that continuously monitors a patient's breathing and delivers mild stimulation to the hypoglossal nerve to keep the airway open. Clinical data, including a publication in the New England Journal of Medicine and over 385 peer-reviewed publications, supports the safety and effectiveness of Inspire therapy. The FDA granted premarket approval ("PMA") for Inspire therapy in 2014. It has been commercially available in certain European markets since 2011, and Japan's Ministry of Health, Labour and Welfare ("MLHW") approved it in 2018. Inspire therapy is indicated for patients with moderate to severe OSA who do not have significant central sleep apnea and do not have a complete concentric collapse of the airway at the soft palate level. More than 125,000 patients have been treated with Inspire therapy in the United States ("U.S."), Europe, and Asia. OSA is a chronic disease where breathing is interrupted during sleep due to a partially or completely blocked airway. Moderate OSA is defined by an apnea-hypopnea index ("AHI") of 15 to 30 events per hour, while severe OSA involves an AHI of 30 or more events per hour.

Inspire Medical Systems, Inc. (NYSE:INSP) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for INSP at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for INSP spans 10-Q, 8-K, DEF 14A, PRE 14A.

Recent high-impact activity:

  • Inspire 10-Q Details $24.4M Q3 Loss on $24.1M Restructuring, $7.0M Legal Settlement
  • Inspire Q3 Revenue Falls 7.9% to $206.7M; FY26 Guidance Narrowed, New CPT Code Set for 2028
  • Inspire Medical Posts 84-Cent Quarterly Loss Per Share
  • Inspire Medical Systems Raises 2026 Guidance, Announces Strategic Growth Plan
  • Inspire Medical Posts 2Q EPS of 1c, First Glimpse of Quarterly Performance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$911.98M
Net Income
$145.42M
Diluted EPS
$4.89
Op. Cash Flow
$116.98M
Free Cash Flow
$78.48M
Gross Profit
$778.76M
Operating Income
$50.95M
Cash & Equivalents
$104.81M
Debt / Equity
0.00×
Net Margin
15.9%
Shares Outstanding
28.58M sh
Source: 10-K · filed 2026-02-13 · accession 0001609550-26-000016

Short Interest & Short Volume

6.62 days to cover

FINRA reported short interest of 4,144,263 shares in INSP as of the October 30, 2026 settlement, a 7.7% decrease from the prior period — about 6.6 days to cover at its recent average daily volume. On November 20, 2026, 57.7% of INSP volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,144,263 shares as of October 30, 2026
Change vs prior period▼ 7.7%
Days to cover6.62 at avg daily volume of 625,586
Daily short volume (FINRA facilities)57.7% of 186,914 shares on November 20, 2026
5-day average short volume59.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with I →
$55.1
52-week range · as of 2026-11-02 $38.91 – $147.03
Market cap
$1.6B
Volume
552.3K (0.8× avg)
3-mo avg 695.8K
Live data · 2026-11-21 16:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed INSP - Latest Insights

INSP
Nov 02, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $67.00
Real-time Price: $55.10 info
Change: -$11.90 (-18%) info
Market Cap: $1.596B info
INSP
Nov 02, 2026, 4:29 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $67.15
Real-time Price: $55.10 info
Change: -$12.05 (-18%) info
Market Cap: $1.596B info
INSP
Nov 02, 2026, 4:28 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $67.21
Real-time Price: $55.10 info
Change: -$12.11 (-18%) info
Market Cap: $1.596B info
INSP
Aug 03, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $59.60
Real-time Price: $55.10 info
Change: -$4.50 (-8%) info
Market Cap: $1.596B info
INSP
Aug 03, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $53.63
Real-time Price: $55.10 info
Change: +$1.47 (+3%) info
Market Cap: $1.596B info
INSP
Jun 26, 2026, 6:41 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $43.11
Real-time Price: $55.10 info
Change: +$11.99 (+28%) info
Market Cap: $1.596B info
INSP
May 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $47.37
Real-time Price: $55.10 info
Change: +$7.73 (+16%) info
Market Cap: $1.596B info
INSP
May 04, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $47.02
Real-time Price: $55.10 info
Change: +$8.08 (+17%) info
Market Cap: $1.596B info
INSP
May 04, 2026, 4:02 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $52.00
Real-time Price: $55.10 info
Change: +$3.10 (+6%) info
Market Cap: $1.596B info
INSP
Mar 20, 2026, 7:51 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $54.62
Real-time Price: $55.10 info
Change: +$0.480 (+0.88%) info
Market Cap: $1.596B info
INSP
Mar 09, 2026, 4:37 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $61.89
Real-time Price: $55.10 info
Change: -$6.79 (-11%) info
Market Cap: $1.596B info
INSP
Feb 13, 2026, 4:05 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $59.00
Real-time Price: $55.10 info
Change: -$3.90 (-7%) info
Market Cap: $1.596B info
INSP
Feb 11, 2026, 4:32 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $61.00
Real-time Price: $55.10 info
Change: -$5.90 (-10%) info
Market Cap: $1.596B info
INSP
Jan 12, 2026, 5:04 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $96.93
Real-time Price: $55.10 info
Change: -$41.83 (-43%) info
Market Cap: $1.596B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets